Need larger text?

-A A +A

Worldwide Clinical Trials is here in San Antonio and accepting new participants in clinical research trials

When a drug company wants to license a new drug the US Food and Drug Administration (FDA), the European Medicine Agency and other regulatory authorities require the drug be tested on animals first and then a large number of individuals/patients to ensure the drug is both safe and effective.   Important new medications and often old medications in a slightly different form are tested at medical research centers.  San Antonio is fortunate to have a WorldWide Clinical Trials site here – the only site in the US for phase 1 trials (they have many sites in Europe). 

Drug studies have several development stages- including early Phase 1, Phase 2 and Phase 3 research trials.  Phase 1 trials evaluate pharmacokinetics (drug absorption and levels found in the blood after dose administration) as well as safety and tolerability of medications.  Previous studies in animals (rats, dogs, primates) have also addressed safety, efficacy and potential toxicity.  Phase 2 and 3 trials further evaluate efficacy.  In San Antonio we concentrate on Phase 1 studies.  Drug trials allow the medical community to develop new treatments, hopefully more effective or safer than treatments already on the market.  These studies generally compensate individuals quite well for their participation.

At present Worldwide Clinical Trials has at least ten ongoing studies with three studies aimed at evaluation of medications for the healthy older population age 65-75.  We are evaluating several new medications for Alzheimer’s cognitive impairment.   We are running phase 1 trials testing a new non-opiate pain medication for arthritis.  Studies of new drugs to treat tuberculosis, Parkinson’s, Systemic Lupus Erythematosus, Myelofibrosis (aplastic anemia), ALS, Diabetic cardiomyopathy and a number of other conditions are ongoing.   All of these new products have been found to be safe in animal studies to date with no serious side effects. 

Subjects are well compensated and are generally asked to stay at our facility at the 2455 NE 410 Loop Ste 150 site for at least several days.  Lab tests are monitored as well as ecgs and daily monitoring is done by trained medical staff.   Occasionally studies are mostly outpatient.  Some studies  give significant bonuses for study completion.  Trial participants are closely screened and monitored by RNs, paramedics, NPs and MDs.

Please look at our studies by call 210-635-1515 for more information.  Progress in treating serious diseases such as Parkinson’s, ALS, Systemic Lupus Erythematosus and many more is only made when the public is willing to participate in research.   We highly value our subjects and encourage you to find out more and see if a study is right for you!

Ellen Remenchik MD, MPH /  Investigator, Medical Director, Early Phase Studies

Worldwide Clinical Trials

2455 N.E. Loop 410, Suite 150, San Antonio, Texas 78217, USA


Former Assistant Professor, Baylor COM, Mayo COM, UTHSCSA